Atluri Gowtham, Padmanabhan Kanchana, Fang Gang, Steinbach Michael, Petrella Jeffrey R, Lim Kelvin, Macdonald Angus, Samatova Nagiza F, Doraiswamy P Murali, Kumar Vipin
Department of Computer Science and Engineering, University of Minnesota - Twin Cities, USA.
Neuroimage Clin. 2013 Aug 7;3:123-31. doi: 10.1016/j.nicl.2013.07.004.
Neuropsychiatric disorders such as schizophrenia, bipolar disorder and Alzheimer's disease are major public health problems. However, despite decades of research, we currently have no validated prognostic or diagnostic tests that can be applied at an individual patient level. Many neuropsychiatric diseases are due to a combination of alterations that occur in a human brain rather than the result of localized lesions. While there is hope that newer imaging technologies such as functional and anatomic connectivity MRI or molecular imaging may offer breakthroughs, the single biomarkers that are discovered using these datasets are limited by their inability to capture the heterogeneity and complexity of most multifactorial brain disorders. Recently, complex biomarkers have been explored to address this limitation using neuroimaging data. In this manuscript we consider the nature of complex biomarkers being investigated in the recent literature and present techniques to find such biomarkers that have been developed in related areas of data mining, statistics, machine learning and bioinformatics.
精神分裂症、双相情感障碍和阿尔茨海默病等神经精神疾病是重大的公共卫生问题。然而,尽管经过了数十年的研究,但目前我们还没有经过验证的、可应用于个体患者层面的预后或诊断测试。许多神经精神疾病是由人类大脑中发生的多种改变共同导致的,而非局部病变的结果。虽然人们寄希望于功能和解剖连接磁共振成像或分子成像等更新的成像技术可能带来突破,但利用这些数据集发现的单一生物标志物,因其无法捕捉大多数多因素脑部疾病的异质性和复杂性而受到限制。最近,人们探索了复杂生物标志物,利用神经成像数据来解决这一局限性。在本手稿中,我们考虑了近期文献中正在研究的复杂生物标志物的性质,并介绍了在数据挖掘、统计学、机器学习和生物信息学等相关领域中为寻找此类生物标志物而开发的技术。